Go Pro

Bain Capital Specialty Finance (BCSF) Financials

Bain Capital Specialty Finance logo
$11.83 -0.04 (-0.34%)
As of 09/4/2026 03:58 PM Eastern
Annual Income Statements for Bain Capital Specialty Finance

Annual Income Statements for Bain Capital Specialty Finance

This table shows Bain Capital Specialty Finance's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-47 120 105 -23 119 -13
Consolidated Net Income / (Loss)
-47 105 120 -23 132 -13
Net Income / (Loss) Continuing Operations
-47 105 120 -23 132 -13
Total Pre-Tax Income
-47 105 120 -23 132 -13
Total Revenue
-43 163 184 -12 215 -1.81
Net Interest Income / (Expense)
-63 116 114 -80 148 -81
Total Interest Income
0.00 167 166 0.00 222 0.00
Total Interest Expense
63 51 52 80 75 81
Long-Term Debt Interest Expense
63 51 52 80 75 81
Total Non-Interest Income
21 47 70 68 68 79
Other Service Charges
2.16 6.17 15 11 19 9.88
Net Realized & Unrealized Capital Gains on Investments
18 17 17 57 -2.70 69
Total Non-Interest Expense
4.67 58 65 11 83 11
Other Operating Expenses
4.67 39 45 11 54 11
Basic Earnings per Share
$0.14 $1.86 $1.63 $1.91 $1.85 $1.53
Weighted Average Basic Shares Outstanding
58.67M 64.56M 64.56M 64.56M 64.56M 64.82M
Diluted Earnings per Share
$0.14 $1.86 $1.63 $1.91 $1.85 $1.53
Weighted Average Diluted Shares Outstanding
58.67M 64.56M 64.56M 64.56M 64.56M 64.82M
Weighted Average Basic & Diluted Shares Outstanding
- - 64.56M 64.56M 64.61M 64.87M

Quarterly Income Statements for Bain Capital Specialty Finance

This table shows Bain Capital Specialty Finance's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-9.91 35 29 33 22 -34 16 19 -21 -13 14
Consolidated Net Income / (Loss)
-18 39 28 31 34 -34 16 22 -20 -13 14
Net Income / (Loss) Continuing Operations
-18 39 28 31 34 -34 16 22 -20 -13 14
Total Pre-Tax Income
-18 39 28 31 34 -34 16 22 -20 -13 14
Total Revenue
-28 62 49 52 53 -31 18 40 -48 -9.74 27
Net Interest Income / (Expense)
-77 38 37 37 35 -19 -22 34 -128 -20 25
Total Interest Income
-58 56 55 55 56 0.00 0.00 54 -108 0.00 45
Investment Securities Interest Income
- 56 55 55 56 - - 54 - - 45
Total Interest Expense
19 18 18 18 21 19 22 20 20 20 21
Long-Term Debt Interest Expense
19 18 18 18 21 19 22 20 20 20 21
Total Non-Interest Income
49 24 12 14 18 -12 40 5.88 80 11 2.43
Other Service Charges
2.38 5.26 3.14 5.70 4.50 2.88 4.16 1.61 1.24 1.50 1.81
Net Realized & Unrealized Capital Gains on Investments
62 5.17 -5.45 -2.89 0.47 -15 36 -7.39 103 9.01 -15
Other Non-Interest Income
- 14 14 11 13 - - 12 - - 15
Total Non-Interest Expense
-11 22 22 20 19 3.29 2.64 18 -28 2.77 13
Insurance Policy Acquisition Costs
- 9.23 7.92 7.02 4.70 - - 4.60 - - 0.80
Other Operating Expenses
-6.67 13 14 13 14 3.29 2.64 13 -18 2.77 12
Basic Earnings per Share
$0.49 $0.55 $0.45 $0.51 $0.34 $0.44 $0.37 $0.29 $0.43 $0.05 $0.22
Weighted Average Basic Shares Outstanding
64.56M 64.56M 64.56M 64.56M 64.56M 64.68M 64.87M 64.87M 64.82M 64.87M 64.87M
Diluted Earnings per Share
$0.49 $0.55 $0.45 $0.51 $0.34 $0.44 $0.37 $0.29 $0.43 $0.05 $0.22
Weighted Average Diluted Shares Outstanding
64.56M 64.56M 64.56M 64.56M 64.56M 64.68M 64.87M 64.87M 64.82M 64.87M 64.87M
Basic & Diluted Earnings per Share
- - $0.51 $0.53 - - - $0.45 - - $0.44
Weighted Average Basic & Diluted Shares Outstanding
64.56M 64.56M 64.56M 64.56M 64.61M 64.87M 64.87M 64.87M 64.87M 64.87M 64.87M

Annual Cash Flow Statements for Bain Capital Specialty Finance

This table details how cash moves in and out of Bain Capital Specialty Finance's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
13 127 -79 -12 -13 -42
Net Cash From Operating Activities
89 266 -317 219 -27 30
Net Cash From Continuing Operating Activities
89 266 -317 219 -27 30
Net Income / (Loss) Continuing Operations
8.28 120 105 123 119 99
Consolidated Net Income / (Loss)
8.28 120 105 123 119 99
Amortization Expense
-3.23 0.06 -1.04 -1.76 -1.13 0.05
Non-Cash Adjustments to Reconcile Net Income
78 167 -393 109 -125 -45
Changes in Operating Assets and Liabilities, net
-22 -21 -28 -12 -21 -24
Net Cash From Investing Activities
0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Continuing Investing Activities
0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Financing Activities
-77 -139 238 -231 14 -72
Net Cash From Continuing Financing Activities
-77 -139 238 -231 14 -72
Issuance of Debt
597 1,425 793 348 867 1,306
Issuance of Common Equity
132 - - 0.00 0.00 5.48
Repayment of Debt
-716 -1,476 -467 -480 -738 -1,238
Payment of Dividends
-86 -88 -88 -99 -114 -146
Cash Interest Paid
68 47 43 75 70 77
Cash Income Taxes Paid
0.00 0.24 0.13 0.83 2.25 3.34

Quarterly Cash Flow Statements for Bain Capital Specialty Finance

This table details how cash moves in and out of Bain Capital Specialty Finance's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
6.57 10 -24 -39 40 -5.29 78 -88 -28 -25 98
Net Cash From Operating Activities
149 -64 192 -136 -20 -7.27 0.65 9.00 27 27 71
Net Cash From Continuing Operating Activities
148 -64 193 -136 -20 -7.27 0.65 9.00 27 27 71
Net Income / (Loss) Continuing Operations
31 35 29 33 22 29 24 19 28 3.39 14
Consolidated Net Income / (Loss)
31 35 29 33 22 29 24 19 28 3.39 14
Amortization Expense
-0.01 -0.58 -0.09 -0.03 -0.43 -0.41 0.05 0.41 -0.01 -0.21 1.38
Non-Cash Adjustments to Reconcile Net Income
119 -102 174 -161 -34 -49 -6.65 -26 37 32 77
Changes in Operating Assets and Liabilities, net
-2.76 3.49 -11 -7.48 -7.87 14 -16 16 -38 -9.02 -22
Net Cash From Financing Activities
-142 74 -217 97 60 1.98 78 -97 -55 -51 27
Net Cash From Continuing Financing Activities
-142 74 -217 97 60 1.98 78 -97 -55 -51 27
Issuance of Debt
20 198 99 268 302 459 300 406 141 643 84
Repayment of Debt
-135 -97 -286 -142 -213 -404 -193 -473 -167 -657 -30
Payment of Dividends
-27 -27 -29 -29 -29 -58 -29 -29 -29 -37 -27
Cash Interest Paid
20 18 18 16 19 20 18 20 19 20 22
Cash Income Taxes Paid
0.00 2.25 - 0.16 -0.16 3.34 - - - 0.00 3.36

Annual Balance Sheets for Bain Capital Specialty Finance

This table presents Bain Capital Specialty Finance's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
2,571 2,592 2,472 2,632 2,663
Cash and Due from Banks
117 30 43 52 23
Restricted Cash
86 66 63 46 33
Trading Account Securities
5.32 0.06 0.00 2,436 0.00
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00
Deferred Acquisition Cost
2.18 3.74 2.80 - 3.54
Other Assets
77 100 2,351 83 100
Total Liabilities & Shareholders' Equity
2,571 2,592 2,472 2,632 2,663
Total Liabilities
1,471 1,476 1,336 1,492 1,545
Accrued Interest Payable
7.06 12 13 14 12
Long-Term Debt
1,415 1,385 1,256 1,390 1,471
Other Long-Term Liabilities
49 79 48 60 62
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,100 1,116 1,136 1,140 1,117
Total Preferred & Common Equity
1,100 1,116 1,136 1,140 1,117
Total Common Equity
1,168 1,116 1,136 1,140 1,117
Common Stock
1,168 1,168 1,168 1,160 1,161
Retained Earnings
- -52 -32 -20 -44

Quarterly Balance Sheets for Bain Capital Specialty Finance

This table presents Bain Capital Specialty Finance's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
2,606 2,675 2,566 2,580 2,415 2,544 2,642 2,774 2,716 2,602 2,620
Cash and Due from Banks
23 88 65 47 18 25 10 28 41 13 97
Restricted Cash
51 36 26 74 67 29 56 137 26 18 18
Trading Account Securities
1.11 0.06 5.85 0.92 0.65 - 1.47 0.00 0.00 2,476 2,370
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
125 161 2,443 2,449 91 77 2,509 105 2,590 78 109
Total Liabilities & Shareholders' Equity
2,606 2,675 2,566 2,580 2,415 2,544 2,642 2,774 2,716 2,602 2,620
Total Liabilities
1,485 1,550 1,434 1,438 1,272 1,397 1,498 1,635 1,587 1,508 1,540
Accrued Interest Payable
14 16 15 13 12 13 12 14 13 11 8.60
Other Short-Term Payables
- - - - - - 0.00 - - 17 13
Long-Term Debt
1,408 1,490 1,370 1,358 1,174 1,301 1,451 1,563 1,496 1,455 1,501
Other Long-Term Liabilities
63 44 42 49 87 83 25 59 63 6.27 2.39
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,168 1,126 1,133 1,143 1,143 1,147 1,145 1,139 1,129 1,094 1,080
Total Preferred & Common Equity
1,121 1,126 1,133 1,143 1,143 1,147 1,145 1,139 1,129 1,094 1,080
Total Common Equity
1,168 1,126 1,133 1,143 1,143 1,147 1,145 1,139 1,129 1,094 1,080
Common Stock
1,168 1,168 1,168 1,165 1,165 1,165 1,164 1,164 1,164 1,161 1,161
Retained Earnings
- -43 -36 -23 -23 -19 -20 -25 -36 -68 -81

Annual Metrics And Ratios for Bain Capital Specialty Finance

This table displays calculated financial ratios and metrics derived from Bain Capital Specialty Finance's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - 64,868,507.00
DEI Adjusted Shares Outstanding
- - - - - 64,868,507.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - -0.20
Growth Metrics
- - - - - -
Revenue Growth
0.00% 481.63% 13.00% -106.66% 1,854.77% -100.84%
EBITDA Growth
0.00% 563.96% 13.26% -121.30% 617.59% -109.97%
EBIT Growth
0.00% 321.00% 14.31% -119.64% 661.08% -109.92%
NOPAT Growth
0.00% 415.72% 14.31% -113.75% 901.54% -106.94%
Net Income Growth
0.00% 321.00% 14.31% -119.64% 661.08% -109.92%
EPS Growth
0.00% 1,228.57% -12.37% 17.18% -3.14% -17.30%
Operating Cash Flow Growth
0.00% 196.98% -219.31% 169.21% -112.36% 208.95%
Free Cash Flow Firm Growth
0.00% 0.00% 105.52% -30.24% -105.97% -1,117.57%
Invested Capital Growth
0.00% 0.00% -0.53% -4.37% 5.75% 2.30%
Revenue Q/Q Growth
0.00% 0.00% 0.00% -110.47% 60.59% -101.83%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -142.75% 64.46% -132.40%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -138.44% 64.43% -132.22%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -127.93% 64.43% -122.56%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -134.37% 64.43% -132.22%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% -7.50% 6.25%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -1.95% 64.08% -119.14% 267.65%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -104.08% 50.81%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -4.41% 3.38% -1.40%
Profitability Metrics
- - - - - -
EBITDA Margin
0.00% 64.28% 64.42% 0.00% 60.79% 0.00%
EBIT Margin
0.00% 64.24% 64.99% 0.00% 61.31% 0.00%
Profit (Net Income) Margin
0.00% 64.24% 64.99% 0.00% 61.31% 0.00%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 8.33% 4.77% 0.00% 5.36% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 8.33% 4.77% 0.00% 5.36% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 10.72% 6.03% 0.00% 6.24% 0.00%
Return on Equity (ROE)
0.00% 19.05% 10.81% -2.09% 11.60% -1.16%
Cash Return on Invested Capital (CROIC)
0.00% -191.67% 5.30% 3.79% -0.23% -2.63%
Operating Return on Assets (OROA)
0.00% 4.07% 4.64% 0.00% 5.17% 0.00%
Return on Assets (ROA)
0.00% 4.07% 4.64% 0.00% 5.17% 0.00%
Return on Common Equity (ROCE)
0.00% 20.23% 11.14% -2.09% 11.60% -1.16%
Return on Equity Simple (ROE_SIMPLE)
0.00% 9.52% 10.73% -2.07% 11.58% -1.17%
Net Operating Profit after Tax (NOPAT)
-33 105 120 -16 132 -9.17
NOPAT Margin
0.00% 64.24% 64.99% 0.00% 61.31% 0.00%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 0.53% 0.00% 0.27%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 35.76% 35.01% 0.00% 38.69% 0.00%
Earnings before Interest and Taxes (EBIT)
-47 105 120 -24 132 -13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-23 105 119 -25 131 -13
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.54 0.75 0.97 0.81
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.54 0.75 0.97 0.81
Price to Revenue (P/Rev)
0.00 0.00 3.25 0.00 5.11 0.00
Price to Earnings (P/E)
0.00 0.00 5.68 0.00 9.22 0.00
Dividend Yield
18.31% 12.71% 14.88% 12.15% 8.09% 14.02%
Earnings Yield
0.00% 0.00% 17.62% 0.00% 10.85% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.75 0.84 0.95 0.90
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 10.24 0.00 11.12 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 15.90 0.00 18.29 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 15.76 0.00 18.13 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 15.76 0.00 18.13 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 9.12 0.00 78.49
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 14.19 21.54 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 1.29 1.24 1.11 1.22 1.32
Long-Term Debt to Equity
0.00 1.29 1.24 1.11 1.22 1.32
Financial Leverage
0.00 1.29 1.26 1.17 1.16 1.27
Leverage Ratio
0.00 2.34 2.33 2.25 2.24 2.35
Compound Leverage Factor
0.00 2.34 2.33 2.25 2.24 2.35
Debt to Total Capital
0.00% 56.26% 55.37% 52.50% 54.95% 56.83%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 56.26% 55.37% 52.50% 54.95% 56.83%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% -2.72% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 46.46% 44.63% 47.50% 45.05% 43.17%
Debt to EBITDA
0.00 13.50 11.67 -49.67 10.62 -112.76
Net Debt to EBITDA
0.00 11.56 10.86 -45.47 9.88 -108.48
Long-Term Debt to EBITDA
0.00 13.50 11.67 -49.67 10.62 -112.76
Debt to NOPAT
0.00 13.51 11.57 -76.26 10.53 -160.48
Net Debt to NOPAT
0.00 11.56 10.76 -69.82 9.80 -154.39
Long-Term Debt to NOPAT
0.00 13.51 11.57 -76.26 10.53 -160.48
Noncontrolling Interest Sharing Ratio
0.00% -6.22% -3.09% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - -
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -2,410 133 93 -5.54 -67
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 -46.94 2.54 1.16 -0.07 -0.84
Operating Cash Flow to Interest Expense
1.41 5.17 -6.06 2.74 -0.36 0.37
Operating Cash Flow Less CapEx to Interest Expense
1.41 5.17 -6.06 2.74 -0.36 0.37
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.06 0.07 0.00 0.08 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - -
Invested Capital
0.00 2,515 2,502 2,392 2,530 2,588
Invested Capital Turnover
0.00 0.13 0.07 0.00 0.09 0.00
Increase / (Decrease) in Invested Capital
0.00 2,515 -13 -109 138 58
Enterprise Value (EV)
0.00 0.00 1,888 2,000 2,394 2,317
Market Capitalization
0.00 0.00 599 850 1,101 902
Book Value per Share
$0.00 $18.10 $17.29 $17.60 $17.65 $17.23
Tangible Book Value per Share
$0.00 $18.10 $17.29 $17.60 $17.65 $17.23
Total Capital
0.00 2,515 2,502 2,392 2,530 2,588
Total Debt
0.00 1,415 1,385 1,256 1,390 1,471
Total Long-Term Debt
0.00 1,415 1,385 1,256 1,390 1,471
Net Debt
0.00 1,211 1,289 1,150 1,293 1,415
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
14 0.00 0.00 7.06 0.00 3.93
Net Nonoperating Obligations (NNO)
0.00 1,415 1,385 1,256 1,390 1,471
Total Depreciation and Amortization (D&A)
25 0.06 -1.04 -1.76 -1.13 0.05
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $1.63 $1.91 $1.85 $1.53
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 64.56M 64.56M 64.56M 64.82M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $1.63 $1.91 $1.85 $1.53
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 64.56M 64.56M 64.56M 64.82M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 64.56M 64.56M 64.61M 64.87M
Normalized Net Operating Profit after Tax (NOPAT)
-33 73 84 -16 92 -9.17
Normalized NOPAT Margin
0.00% 44.97% 45.49% 0.00% 42.92% 0.00%
Pre Tax Income Margin
0.00% 64.24% 64.99% 0.00% 61.31% 0.00%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
-0.75 2.04 2.29 -0.29 1.77 -0.16
NOPAT to Interest Expense
-0.52 2.04 2.29 -0.21 1.77 -0.11
EBIT Less CapEx to Interest Expense
-0.75 2.04 2.29 -0.29 1.77 -0.16
NOPAT Less CapEx to Interest Expense
-0.52 2.04 2.29 -0.21 1.77 -0.11
Payout Ratios
- - - - - -
Dividend Payout Ratio
-181.94% 83.81% 73.32% -422.60% 86.57% -1,113.70%
Augmented Payout Ratio
-181.94% 83.81% 73.32% -422.60% 86.57% -1,113.70%

Quarterly Metrics And Ratios for Bain Capital Specialty Finance

This table displays calculated financial ratios and metrics derived from Bain Capital Specialty Finance's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - 64,868,507.00 64,868,507.00 64,868,507.00
DEI Adjusted Shares Outstanding
- - - - - - - - 64,868,507.00 64,868,507.00 64,868,507.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - -0.30 -0.19 0.21
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-127.99% 2,261.24% -7.60% 250.07% 287.08% -149.90% -23.74% -23.35% -190.72% 68.32% 47.96%
EBITDA Growth
-126.38% 725.68% -24.26% 182.02% 291.05% -189.79% -31.26% -28.47% -158.12% 63.07% -2.40%
EBIT Growth
-126.25% 843.10% -25.00% 182.91% 293.55% -187.43% -31.67% -29.85% -157.36% 63.24% -10.98%
NOPAT Growth
-119.01% 1,161.57% -25.00% 218.44% 376.50% -161.20% -31.67% -29.85% -140.15% 63.24% -10.98%
Net Income Growth
-123.70% 843.10% -25.00% 182.91% 293.55% -187.43% -31.67% -29.85% -157.36% 63.24% -10.98%
EPS Growth
0.00% 22.22% 0.00% -1.92% -30.61% -20.00% -17.78% -43.14% 26.47% -88.64% -40.54%
Operating Cash Flow Growth
135.81% -48.26% 2,293.15% -211.07% -113.44% 88.59% -99.66% 106.62% 235.86% 466.43% 10,857.59%
Free Cash Flow Firm Growth
0.00% 102.69% 112.66% 103.43% -206.68% -275.51% -212.17% -279.78% 30.39% 132.44% 136.25%
Invested Capital Growth
-4.37% -1.15% -11.43% -2.22% 5.75% 3.82% 16.63% 7.26% 2.30% -1.83% -4.45%
Revenue Q/Q Growth
17.63% 317.76% -20.17% 4.81% 2.68% -158.09% 221.88% 5.44% -221.62% 79.73% 376.47%
EBITDA Q/Q Growth
53.50% 318.71% -28.48% 12.76% 8.32% -202.79% 154.68% 17.50% -188.11% 35.09% 219.79%
EBIT Q/Q Growth
53.05% 322.04% -29.29% 12.48% 9.61% -200.30% 155.18% 15.63% -189.74% 36.12% 210.73%
NOPAT Q/Q Growth
53.05% 417.20% -29.29% 12.48% 9.61% -170.21% 178.82% 15.63% -162.82% 36.12% 258.18%
Net Income Q/Q Growth
53.05% 322.04% -29.29% 12.48% 9.61% -200.30% 155.18% 15.63% -189.74% 36.12% 210.73%
EPS Q/Q Growth
-5.77% 12.24% -18.18% 13.33% -33.33% 29.41% -15.91% -21.62% 48.28% -88.37% 340.00%
Operating Cash Flow Q/Q Growth
21.56% -142.83% 402.14% -170.60% 85.29% 63.63% 108.89% 1,292.57% 201.81% -1.90% 165.75%
Free Cash Flow Firm Q/Q Growth
103.84% -29.74% 379.39% -73.45% -219.30% -15.58% -206.34% 57.44% 53.83% 153.82% 245.83%
Invested Capital Q/Q Growth
-4.41% 4.50% -7.34% 5.64% 3.38% 2.60% 4.08% -2.84% -1.40% -1.55% 1.31%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
0.00% 62.56% 56.05% 60.30% 63.61% 0.00% 50.50% 56.27% 0.00% 0.00% 56.57%
EBIT Margin
0.00% 63.50% 56.24% 60.35% 64.42% 0.00% 50.36% 55.23% 0.00% 0.00% 51.44%
Profit (Net Income) Margin
0.00% 63.50% 56.24% 60.35% 64.42% 0.00% 50.36% 55.23% 0.00% 0.00% 51.44%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 1.32% 1.10% 3.27% 5.64% 0.00% 2.23% 2.16% 0.00% 0.00% 0.54%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 1.32% 1.10% 3.27% 5.64% 0.00% 2.23% 2.16% 0.00% 0.00% 0.54%
Return on Net Nonoperating Assets (RNNOA)
0.00% 1.55% 1.29% 3.83% 6.55% 0.00% 2.68% 2.66% 0.00% 0.00% 0.75%
Return on Equity (ROE)
-2.09% 2.87% 2.39% 7.10% 12.19% 0.00% 4.91% 4.82% -1.16% 0.00% 1.29%
Cash Return on Invested Capital (CROIC)
3.79% 1.98% 12.59% 5.49% -0.23% -1.45% -13.36% -5.41% -2.63% 2.17% 4.80%
Operating Return on Assets (OROA)
0.00% 1.28% 1.06% 3.17% 5.43% 0.00% 2.16% 2.08% 0.00% 0.00% 0.53%
Return on Assets (ROA)
0.00% 1.28% 1.06% 3.17% 5.43% 0.00% 2.16% 2.08% 0.00% 0.00% 0.53%
Return on Common Equity (ROCE)
-2.09% 2.87% 2.39% 7.10% 12.19% 0.00% 4.91% 4.82% -1.16% 0.00% 1.29%
Return on Equity Simple (ROE_SIMPLE)
0.00% 1.83% 1.02% 7.00% 0.00% 5.13% 4.38% 3.60% 0.00% 0.77% 0.62%
Net Operating Profit after Tax (NOPAT)
-12 39 28 31 34 -24 19 22 -14 -8.76 14
NOPAT Margin
0.00% 63.50% 56.24% 60.35% 64.42% 0.00% 50.36% 55.23% 0.00% 0.00% 51.44%
Net Nonoperating Expense Percent (NNEP)
0.40% 0.00% 0.00% 0.00% 0.00% 0.73% 0.00% 0.00% 0.41% 0.26% 0.00%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 36.50% 43.76% 39.65% 35.58% 0.00% 49.64% 44.77% 0.00% 0.00% 48.56%
Earnings before Interest and Taxes (EBIT)
-18 39 28 31 34 -34 19 22 -20 -13 14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-18 39 28 31 34 -35 19 22 -20 -13 15
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.75 0.80 0.85 0.89 0.97 0.94 0.86 0.82 0.81 0.74 0.75
Price to Tangible Book Value (P/TBV)
0.75 0.80 0.85 0.89 0.97 0.94 0.86 0.82 0.81 0.74 0.75
Price to Revenue (P/Rev)
0.00 17.43 20.20 7.58 5.11 8.73 8.77 9.32 0.00 41.91 29.09
Price to Earnings (P/E)
0.00 54.06 58.06 11.63 9.22 21.40 21.80 30.45 0.00 95.41 117.26
Dividend Yield
12.15% 8.87% 8.76% 8.57% 8.09% 11.02% 14.96% 15.79% 14.02% 15.48% 13.42%
Earnings Yield
0.00% 1.85% 1.72% 8.59% 10.85% 4.67% 4.59% 3.28% 0.00% 1.05% 0.85%
Enterprise Value to Invested Capital (EV/IC)
0.84 0.86 0.89 0.92 0.95 0.95 0.88 0.90 0.90 0.87 0.85
Enterprise Value to Revenue (EV/Rev)
0.00 41.14 42.80 16.88 11.12 20.00 21.33 23.72 0.00 116.10 78.70
Enterprise Value to EBITDA (EV/EBITDA)
0.00 110.55 194.62 28.43 18.29 42.59 48.33 58.46 0.00 256.82 264.71
Enterprise Value to EBIT (EV/EBIT)
0.00 102.93 177.10 28.18 18.13 41.89 47.54 57.92 0.00 264.32 326.88
Enterprise Value to NOPAT (EV/NOPAT)
0.00 102.93 177.10 28.18 18.13 41.89 47.54 57.92 0.00 264.32 326.88
Enterprise Value to Operating Cash Flow (EV/OCF)
9.12 10.82 5.16 15.98 0.00 83.83 0.00 0.00 78.49 35.13 16.45
Enterprise Value to Free Cash Flow (EV/FCFF)
21.54 43.07 6.64 16.65 0.00 0.00 0.00 0.00 0.00 39.85 17.33
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.11 1.19 1.03 1.13 1.22 1.27 1.37 1.33 1.32 1.33 1.39
Long-Term Debt to Equity
1.11 1.19 1.03 1.13 1.22 1.27 1.37 1.33 1.32 1.33 1.39
Financial Leverage
1.17 1.18 1.17 1.17 1.16 1.23 1.20 1.23 1.27 1.30 1.38
Leverage Ratio
2.25 2.24 2.24 2.24 2.24 2.28 2.27 2.31 2.35 2.34 2.43
Compound Leverage Factor
2.25 2.24 2.24 2.24 2.24 2.28 2.27 2.31 2.35 2.34 2.43
Debt to Total Capital
52.50% 54.30% 50.68% 53.15% 54.95% 55.91% 57.84% 57.01% 56.83% 57.09% 58.15%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
52.50% 54.30% 50.68% 53.15% 54.95% 55.91% 57.84% 57.01% 56.83% 57.09% 58.15%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
47.50% 45.70% 49.32% 46.85% 45.05% 44.09% 42.16% 42.99% 43.17% 42.91% 41.85%
Debt to EBITDA
-49.67 69.90 110.84 16.34 10.62 25.14 31.82 37.17 -112.76 167.65 180.82
Net Debt to EBITDA
-45.47 63.70 102.78 15.66 9.88 24.00 28.46 35.50 -108.48 164.12 166.88
Long-Term Debt to EBITDA
-49.67 69.90 110.84 16.34 10.62 25.14 31.82 37.17 -112.76 167.65 180.82
Debt to NOPAT
-76.26 65.07 100.86 16.20 10.53 24.73 31.30 36.83 -160.48 172.54 223.28
Net Debt to NOPAT
-69.82 59.31 93.52 15.52 9.80 23.61 28.00 35.18 -154.39 168.91 206.08
Long-Term Debt to NOPAT
-76.26 65.07 100.86 16.20 10.53 24.73 31.30 36.83 -160.48 172.54 223.28
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
97 68 327 87 -103 -120 -366 -156 -72 39 134
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
5.04 3.77 18.52 4.79 -4.95 -6.32 -16.82 -7.68 -3.67 1.91 6.48
Operating Cash Flow to Interest Expense
7.73 -3.53 10.91 -7.50 -0.96 -0.38 0.03 0.44 1.39 1.32 3.43
Operating Cash Flow Less CapEx to Interest Expense
7.73 -3.53 10.91 -7.50 -0.96 -0.38 0.03 0.44 1.39 1.32 3.43
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.02 0.02 0.05 0.08 0.05 0.04 0.04 0.00 0.01 0.01
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,392 2,500 2,316 2,447 2,530 2,596 2,702 2,625 2,588 2,548 2,581
Invested Capital Turnover
0.00 0.02 0.02 0.05 0.09 0.05 0.04 0.04 0.00 0.01 0.01
Increase / (Decrease) in Invested Capital
-109 -29 -299 -56 138 96 385 178 58 -47 -120
Enterprise Value (EV)
2,000 2,147 2,061 2,263 2,394 2,458 2,373 2,354 2,317 2,228 2,198
Market Capitalization
850 910 973 1,017 1,101 1,073 976 924 902 804 812
Book Value per Share
$17.60 $17.70 $17.70 $17.76 $17.65 $17.71 $17.56 $17.40 $17.23 $16.86 $16.65
Tangible Book Value per Share
$17.60 $17.70 $17.70 $17.76 $17.65 $17.71 $17.56 $17.40 $17.23 $16.86 $16.65
Total Capital
2,392 2,500 2,316 2,447 2,530 2,596 2,702 2,625 2,588 2,548 2,581
Total Debt
1,256 1,358 1,174 1,301 1,390 1,451 1,563 1,496 1,471 1,455 1,501
Total Long-Term Debt
1,256 1,358 1,174 1,301 1,390 1,451 1,563 1,496 1,471 1,455 1,501
Net Debt
1,150 1,237 1,089 1,246 1,293 1,385 1,398 1,429 1,415 1,424 1,385
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
5.29 0.00 0.00 0.00 0.00 10 0.00 0.00 5.88 3.75 0.00
Net Nonoperating Obligations (NNO)
1,256 1,358 1,174 1,301 1,390 1,451 1,563 1,496 1,471 1,455 1,501
Total Depreciation and Amortization (D&A)
-0.01 -0.58 -0.09 -0.03 -0.43 -0.41 0.05 0.41 -0.01 -0.21 1.38
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.49 $0.55 $0.45 $0.51 $0.34 $0.44 $0.37 $0.29 $0.43 $0.05 $0.22
Adjusted Weighted Average Basic Shares Outstanding
64.56M 64.56M 64.56M 64.56M 64.56M 64.68M 64.87M 64.87M 64.82M 64.87M 64.87M
Adjusted Diluted Earnings per Share
$0.49 $0.55 $0.45 $0.51 $0.34 $0.44 $0.37 $0.29 $0.43 $0.05 $0.22
Adjusted Weighted Average Diluted Shares Outstanding
64.56M 64.56M 64.56M 64.56M 64.56M 64.68M 64.87M 64.87M 64.82M 64.87M 64.87M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.47 $0.45 $0.00 $0.00 $0.44
Adjusted Weighted Average Basic & Diluted Shares Outstanding
64.56M 64.56M 64.56M 64.56M 64.61M 64.87M 64.87M 64.87M 64.87M 64.87M 64.87M
Normalized Net Operating Profit after Tax (NOPAT)
-12 27 19 22 24 -24 13 15 -14 -8.76 9.70
Normalized NOPAT Margin
0.00% 44.45% 39.37% 42.25% 45.10% 0.00% 35.25% 38.66% 0.00% 0.00% 36.00%
Pre Tax Income Margin
0.00% 63.50% 56.24% 60.35% 64.42% 0.00% 50.36% 55.23% 0.00% 0.00% 51.44%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-0.92 2.17 1.57 1.72 1.63 -1.81 0.87 1.07 -1.00 -0.62 0.67
NOPAT to Interest Expense
-0.64 2.17 1.57 1.72 1.63 -1.27 0.87 1.07 -0.70 -0.43 0.67
EBIT Less CapEx to Interest Expense
-0.92 2.17 1.57 1.72 1.63 -1.81 0.87 1.07 -1.00 -0.62 0.67
NOPAT Less CapEx to Interest Expense
-0.64 2.17 1.57 1.72 1.63 -1.27 0.87 1.07 -0.70 -0.43 0.67
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-422.60% 495.16% 926.36% 139.93% 86.57% 247.82% 291.53% 358.52% -1,113.70% 1,477.26% 1,823.62%
Augmented Payout Ratio
-422.60% 495.16% 926.36% 139.93% 86.57% 247.82% 291.53% 358.52% -1,113.70% 1,477.26% 1,823.62%

Financials Breakdown Chart

Key Financial Trends

BCSF’s second quarter of 2026 showed a sharp operating recovery from the first quarter. Total interest income increased to $45.2 million from zero in Q1 2026, producing net interest income of $24.5 million versus a $20.3 million net interest loss. Total revenue reached $26.9 million, and net income attributable to common shareholders was reported at $14.1 million, compared with a $12.5 million loss in Q1. However, Q2 earnings remained below the $29.1 million reported in Q2 2024 and the $33.1 million reported in Q3 2024.

The latest balance sheet was relatively stable in size, with total assets of $2.62 billion at June 30, 2026, up modestly from $2.60 billion in Q1 but below $2.77 billion in Q2 2025. Cash and restricted cash totaled approximately $115.7 million, a substantial increase from $30.3 million in the prior quarter. Trading account securities represented $2.37 billion of assets, although this classification changed significantly across the historical periods provided, limiting direct portfolio comparisons. Long-term debt rose to $1.50 billion from $1.45 billion in Q1, while total equity declined to $1.08 billion.

Cash generation improved considerably in Q2 2026. Operating cash flow was $70.8 million, compared with $26.6 million in Q1 and only $0.6 million in Q2 2025. Debt issuance of $84.0 million exceeded $30.0 million of repayments, and the company paid $27.2 million in dividends. Still, Q2 operating cash flow benefited from $77.5 million of noncash adjustments and was reduced by a $22.1 million change in operating assets and liabilities. Investors should also note that many historical income statement and cash flow figures were restated or calculated, and several reported EPS values do not reconcile cleanly with the corresponding net income figures.

  • Return to positive net interest income: Q2 2026 net interest income was $24.5 million after a $20.3 million loss in Q1, indicating that investment income resumed after the unusual first-quarter presentation.
  • Stronger operating cash flow: Operating cash flow increased to $70.8 million in Q2 2026, providing substantially better support for dividends and financing needs.
  • Improved liquidity: Cash and restricted cash increased by approximately $85.4 million sequentially to $115.7 million, while total cash increased by $97.5 million during the quarter.
  • Dividend support: The company paid $27.2 million in dividends during Q2 while still producing positive operating cash flow and ending the quarter with a cash increase.
  • Balance-sheet scale remained substantial: Total assets of $2.62 billion and common equity of $1.08 billion provide a sizeable capital base for the investment portfolio.
  • Non-interest income was mixed: Other non-interest income of $15.3 million and service charges of $1.8 million largely offset a $14.7 million net realized and unrealized investment loss.
  • Portfolio classification changed materially: Trading account securities increased from zero in Q3 2025 to more than $2.4 billion by Q1 2026, making long-term asset mix comparisons difficult without additional portfolio disclosures.
  • Debt remains high: Long-term debt of $1.50 billion equaled roughly 57% of total assets, and interest expense increased to $20.7 million from $18.1 million in Q3 2024.
  • Equity has weakened: Total common equity declined from $1.15 billion in Q2 2024 to $1.08 billion in Q2 2026, while retained earnings became more negative, reaching approximately $80.8 million below zero.
  • Earnings remain volatile and difficult to evaluate: BCSF recorded losses in Q1 2025, Q4 2025 and Q1 2026, while investment gains and losses have caused large swings in reported revenue. Restatements and inconsistent EPS data further reduce the reliability of simple quarter-to-quarter comparisons.
09/05/26 12:41 AM ETAI Generated. May Contain Errors.

Bain Capital Specialty Finance Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Bain Capital Specialty Finance's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Bain Capital Specialty Finance's net income appears to be on an upward trend, with a most recent value of -$13.09 million in 2025, falling from -$47.41 million in 2020. The previous period was $132.01 million in 2024. See Bain Capital Specialty Finance's forecast for analyst expectations on what's next for the company.

Over the last 5 years, Bain Capital Specialty Finance's total revenue changed from -$42.73 million in 2020 to -$1.81 million in 2025, a change of -95.8%.

Bain Capital Specialty Finance's total liabilities were at $1.55 billion at the end of 2025, a 3.5% increase from 2024, and a 5.0% increase since 2021.

In the past 4 years, Bain Capital Specialty Finance's cash and equivalents has ranged from $23.09 million in 2025 to $117.42 million in 2021, and is currently $23.09 million as of their latest financial filing in 2025.

Over the last 5 years, Bain Capital Specialty Finance's book value per share changed from 0.00 in 2020 to 17.23 in 2025, a change of 1,722.6%.



Financial statements for NYSE:BCSF last updated on 8/10/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners